Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-08-26

Clinical Trial Update: Effect of Choline Fenofibrate (SLV348) on Macular Edema [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 study evaluating choline fenofibrate (SLV348) for diabetic macular edema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Choline Fenofibrate (SLV348) (choline fenofibrate)

Snippet

Sponsor: Abbott Products | Conditions: Diabetic Macular Edema | Phase 2 | Status: COMPLETED